QA: Omeros CORP in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001285819_2026_Omeros_CORP.pdf

Logs

Graph

Absolute values for 0001285819, Omeros CORP

  xvar xval
0 AssetsCurrent 215,667,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,768,000
3 remainder_Assets 108,197,000
4 LiabilitiesCurrent 78,062,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,926,102
9 ResearchAndDevelopmentExpense 58,243,223
10 remainder_Expenses 7,036,211
11 remainder_Revenues 5,279,384
12 remainder_NetIncome 90,419,259
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 325,632,000
1 Liabilities 78,062,000
2 Expenses 102,205,536
3 Revenues 5,279,384
4 StockholdersEquity 247,570,000
5 NetIncome -6,506,893
6 ComprehensiveNetIncome -6,506,893
7 BaseVar 300,799,090
8 EconomicCapitalRatiobeforeLimitedLiability 2.64
9 EconomicCapitalRatio 3.45

Edgar->Model Mapping

Feature Distribution

Change over Time